,O WHVWR XIILFLDOH GHOOD /LVWD q GHSRVLWDWR SUHVVR OD :$'$ HG q SXEEOLFDWR LQ ,QJOHVH H )UDQFHVH ,Q FDVR GL GLVSDULWj WUD OD YHUVLRQH ,QJOHVH H TXHOOD )UDQFHVH IDUj IHGH OD YHUVLRQH ,QJOHVH/$ /,67$ '(//( 6267$1=( ( 0(72', 352,%,7,OH 6RVWDQ]H 3URLELWH GHYRQR HVVHUH FRQVLGHUDWH ³6RVWDQ]H 6SHFLILFDWH´ DG HFFH]LRQH GHOOH 6RVWDQ]H LQFOXVH QHOOH FODVVL 64XDOVLDVL VRVWDQ]D IDUPDFRORJLFD QRQ FRPS
Microsoft word - cv patelRakesh C. Patel, M.D.
1812 North Mills Avenue
Orlando, FL 32803
Division of Urology, Department of Surgery
University of Florida Urology Research Award, 2002
Endourological Management of Ureteral Strictures,
Rakesh C. Patel, M.D.
American Urological Association
American College of Surgeons, Resident Candidate
Florida Urological Association
Associate Clinical Professor of Surgery-Division of Urology Presentations:
Perineal Prostatectomy, “How we do it and why” Department of General Surgery Grand Rounds Department of General Surgery Grand Rounds Testicular Cancer – Department of General Surgery Grand Rounds
Ureteral Strictures in Kidney Transplant Recipients University of Florida Experience with Laparoscopic Donor Nephrectomies “A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Study Drug 0.5mg Administered Once Daily for Four Years to Reduce the Risk of Biopsy-Detectable “An Open-Label Study to Evaluate the Efficacy and Safety of Study Drug Administered ‘On Demand’ to Men of Various Populations with Erectile Rakesh C. Patel, M.D.
“Open-Label Study of the Efficacy and Safety of 5mg and 10mg Study Drug in Patients with Overactive Bladder Symptoms” “A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of Study Drug for the Prevention of “REALISE: Real Life Safety and Efficacy on Levitra®” “A Phase 3, Parallel Group, Randomized, Double-Blind, Placebo And Safety of Study Drug Sustained Release in Subjects with “Study of Study Drug in Women of Different Demographic Co-morbidities with Stress Urinary Incontinence: “A Study to Compare the Safety and Efficacy of Once Daily Study Drug Versus Twice Daily Study Drug in the Treatment of Complicated “A Double-Blind, Randomized, Placebo-Controlled Trial of Elmiron® For The Treatment of Chronic, Non-Bacterial Prostatitis” “A Randomized, Double-Blind, Crossover Study to Evaluate the Duration of Erection Following Study Drug 10mg Administration For 4 Weeks in a Fixed-Dose Regimen Compared to Placebo in Males with ED” “An Open-Label, Multicenter Study to Assess the Efficacy and Safety of Daily Oral Administration of 5 and 10mg Study Drug in Patients Who Wish to Switch from Detrol LA for the Treatment of Overactive “Prospective, Observational Registry and Patient Survey of the Management Rakesh C. Patel, M.D.
Double-Blind, Randomized, Parallel Study “A Multicenter, 2 Week, Double-Blind Study of XXXX 60mg QD Morning or In The Evening In Patients With Overactive Bladder” “A Randomized, Double-Blind, Placebo-Controlled, Multicenter Efficacy and Safety Study of XXXX for the Prevention of Prostate Cancer in Men with High Grade Prostate Intraepithelial Neoplasia”
Genomic and personalized medicine, volume 2, , isbn 0123694205, 9780123694201, , isbn 0123694205, 9780123694201, 2009, huntington f. willard, geoffrey s. ginsburg, elsevier/academic press, 2009, ebook
Genomic and Personalized Medicine, Volume 2, , ISBN 0123694205, 9780123694201, , ISBN 0123694205,9780123694201, Huntington F. Willard, Geoffrey S. Ginsburg, Elsevier/Academic Press, 2009, 0123708893,9780123708892, . . The Promise of Low Dose Naltrexone Therapy Potential Benefits in Cancer, Autoimmune, Neurological andInfectious Disorders, Elaine A. Moore, Samantha Wilkinson, 2009, Science, 213